Episodic Headache, Sweating, and Palpitations

An adult has abrupt episodes of pounding headache, sweating, palpitations, pallor, and severe blood-pressure elevation that resolve over twenty minutes. Panic, hyperthyroidism, hypoglycemia, drug effects, and withdrawal are more common, but the spell pattern and an adrenal lesion on prior imaging raise concern for catecholamine excess.

Case focus#

The decision is how to obtain and interpret metanephrine testing under conditions that reduce false positives, review interfering medicines and acute stress, and reserve imaging for a meaningful biochemical or syndromic context. A hypertensive emergency requires immediate organ-directed care before elective diagnostic refinement.

This analysis concentrates on calibration. It compares plausible explanations, asks which observations genuinely discriminate among them, and keeps the working diagnosis open to revision as new evidence arrives.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this pheochromocytoma and paraganglioma analysis, the working frame must remain broad enough to compare Pheochromocytoma or sympathetic paraganglioma, Panic attacks, Thyroid hormone excess, Clinically significant hypoglycemia without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: An endocrine and hypertension clinic with validated metanephrine testing, controlled collection conditions, adrenal imaging, genetics, and experienced perioperative care.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Hypertensive emergency with organ injury: Severe pressure accompanied by encephalopathy, focal deficit, seizure, retinal injury, chest pain, pulmonary edema, acute kidney injury, or aortic symptoms requires monitored intravenous treatment directed to the injured organ.
• Catecholamine crisis or shock: Extreme pressure lability, fever, vomiting, severe abdominal pain, lactic acidosis, cardiomyopathy, pulmonary edema, or hypotensive shock can occur in crisis and requires immediate critical-care support.
• Unstable tachyarrhythmia or ischemia: Sustained rapid rhythm, syncope, ischemic ECG change, rising troponin, or ventricular dysfunction during a spell requires emergency cardiac management while catecholamine excess remains under consideration.
• Procedure or medicine-triggered deterioration: A crisis after anesthesia, tumor manipulation, glucocorticoid, dopamine antagonist, sympathomimetic, or unopposed beta blockade is a major clue and should prevent further provocative exposure.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Pheochromocytoma or sympathetic paraganglioma#

What supports it. Stereotyped spells of headache, sweating, palpitations and pallor, paroxysmal or sustained hypertension, adrenal or extra-adrenal mass, inherited syndrome, and clearly elevated metanephrines support catecholamine-secreting tumor.

What argues against it or keeps uncertainty open. Repeated normal high-quality biochemical testing during an appropriate evaluation lowers probability for most secretory tumors, although very small or biochemically unusual lesions require contextual review.

Discriminating next step. Obtain plasma free or urinary fractionated metanephrines under controlled conditions, then localize with cross-sectional imaging only after convincing biochemistry or a strong inherited or imaging context.

Panic attacks#

What supports it. Fear or catastrophic cognition preceding autonomic symptoms, situational triggers, paresthesias, hyperventilation, and normal blood pressure between episodes can support panic.

What argues against it or keeps uncertainty open. Marked pallor, extreme or highly labile pressure, an adrenal lesion, inherited risk, or unequivocal metanephrine elevation argues against panic as the sole cause.

Discriminating next step. Confirm medical safety and biochemical context first, then assess panic phenomenology and function without using an anxiety history to dismiss objective cardiovascular findings.

Thyroid hormone excess#

What supports it. Persistent heat intolerance, tremor, weight loss, frequent stool, goiter, eye findings, atrial arrhythmia, and suppressed thyroid-stimulating hormone with elevated thyroid hormones support thyroid excess.

What argues against it or keeps uncertainty open. Brief discrete spells with pallor and normal thyroid testing make hyperthyroidism less likely.

Discriminating next step. Measure thyroid-stimulating hormone and free hormone levels and evaluate cause when abnormal, while recognizing that thyroid disease and an adrenal lesion can coexist.

Clinically significant hypoglycemia#

What supports it. Spells during fasting or exertion with sweating, tremor, hunger, cognitive change, and documented low plasma glucose that resolves after glucose support hypoglycemia.

What argues against it or keeps uncertainty open. Severe hypertension with normal glucose during symptoms and high metanephrines favors catecholamine tumor.

Discriminating next step. Document glucose during a spell and confirm symptoms, low glucose, and response as a triad before pursuing insulin-mediated or other fasting evaluations.

Drug effect or withdrawal#

What supports it. Stimulants, decongestants, cocaine, monoamine oxidase interactions, caffeine excess, antidepressant effects, clonidine withdrawal, alcohol withdrawal, or sleep deprivation can produce autonomic episodes and false-positive tests.

What argues against it or keeps uncertainty open. Persistent marked biochemical abnormality after supervised removal of interference and a compatible lesion supports tumor.

Discriminating next step. Create a timed exposure list, stop only medicines that can be changed safely, treat withdrawal, repeat metanephrines under controlled conditions, and never provoke a spell intentionally.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Separate emergency physiology from elective testing. Blood pressure in both arms when appropriate, neurologic and retinal examination, ECG, cardiac markers, kidney tests, urinalysis, and chest or aortic imaging based on symptoms identify acute organ injury. Interpretation: Organ damage requires monitored emergency treatment now; a high number without acute injury permits a slower biochemical plan but still needs safe follow-up.
• Capture spell timing and triggers. Onset, duration, pressure and pulse, pallor or flushing, posture, pain, urination, meals, exertion, medicines, surgery, and family history distinguish catecholamine release from panic, glucose, thyroid, and withdrawal states. Interpretation: Repeated stereotyped spells with objective pressure change raise pretest probability; nonspecific isolated symptoms do not justify indiscriminate imaging.
• Collect metanephrines under valid conditions. Plasma sampling after adequate quiet supine rest or a complete timed urine collection reduces posture, stress, and collection errors; laboratory method and reference conditions matter. Interpretation: Large clear elevations are more concerning; mild elevation during illness, seated sampling, or interference should usually be repeated under standardized conditions before localization.
• Review interference and physiologic stress. Antidepressants, sympathomimetics, levodopa, stimulants, withdrawal, sleep apnea, pain, critical illness, caffeine and nicotine can elevate catecholamine metabolites or create similar spells. Interpretation: Remove or stabilize a plausible factor only when clinically safe, document what remains, and interpret the magnitude and metabolite pattern rather than calling every elevation positive.
• Localize and characterize only after biochemical support. Adrenal-protocol CT or MRI defines size, location, density and anatomy; functional imaging is selected for extra-adrenal, metastatic, multifocal, or genotype-related questions. Interpretation: An incidental adrenal mass without biochemical secretion is not automatically pheochromocytoma; concordant biochemistry and anatomy guide surgery and extent evaluation.
• Assess inherited and metastatic risk. Young age, bilateral or multifocal disease, extra-adrenal location, metastatic behavior, and family tumor history support genetic counseling and tailored surveillance. Interpretation: A pathogenic variant informs imaging, recurrence monitoring, and relatives; inability to obtain testing should not delay necessary alpha blockade or tumor treatment.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

Initial plasma metanephrines drawn while acutely ill and seated are only mildly elevated. After medication review and standardized rested sampling, values are markedly abnormal. Cross-sectional imaging localizes an adrenal lesion, and genetics is discussed because inherited risk affects surveillance and family evaluation.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Treat acute organ injury in monitored care. Use short-acting titratable intravenous therapy, rhythm and heart-failure support, and careful volume management with experienced input; avoid precipitous pressure reduction or drugs that worsen unopposed alpha stimulation.
• Establish alpha blockade before beta blockade. For planned resection, begin appropriate alpha-adrenergic blockade, titrate seated and standing pressure, then add beta blockade only after adequate alpha control when persistent tachycardia requires it.
• Restore volume after alpha control. Catecholamine vasoconstriction can produce chronic volume contraction; guided salt and fluid expansion after blockade improves operative stability but must be modified for heart or kidney failure.
• Use experienced surgical and anesthesia planning. Confirm localization, review multifocal or metastatic disease, define medicine timing, anticipate intraoperative pressure swings, and arrange postoperative glucose, pressure, and adrenal monitoring.
• Continue lifelong risk-based surveillance. Repeat biochemistry and imaging intervals depend on pathology, genetics, location, multiplicity and prior disease; document family counseling and recurrence ownership after surgery.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain why the same blood test can be misleading during stress or under poor collection conditions, and why imaging alone cannot prove hormone secretion. Review emergency symptoms, perioperative preparation, medication sequencing, and the voluntary family implications of genetic testing.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Call emergency services for severe headache with weakness or confusion, chest pain, breathlessness, fainting, sustained palpitations, seizure, or extreme pressure with new symptoms.
• Do not start a beta blocker, decongestant, stimulant, dopamine-blocking antiemetic, or elective procedure without the treating team's review when catecholamine tumor is suspected.
• During alpha blockade, report fainting, severe dizziness, persistent rapid pulse, reduced urine, swelling, or breathlessness so dose and volume strategy can be adjusted.
• After resection, keep scheduled biochemical surveillance and seek reassessment for recurrent spells even if the initial tumor was considered completely removed.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Access to standardized sampling, endocrine surgery, and genetic counseling differs by geography and coverage. Coordinate same-day collection and consultation when possible, provide blood-pressure equipment, and do not let inability to purchase genetic testing delay necessary biochemical or surgical care.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Recognizes catecholamine crisis and separates emergency organ care from elective diagnostic refinement.
• Obtains and interprets metanephrines using posture, rest, illness, medicines, and magnitude.
• Avoids using an incidental adrenal image as proof of hormone secretion.
• Sequences alpha blockade, volume preparation, beta blockade, anesthesia, and surgery safely.
• Links age, location, multiplicity, pathology, genetics, surveillance, and family evaluation.

Key takeaways#

• A classic spell pattern raises suspicion, but controlled biochemical testing is the foundation of diagnosis.
• Mild metanephrine elevation during acute illness or seated stress deserves careful repeat testing, not immediate tumor labeling.
• When disease is confirmed, alpha blockade precedes beta blockade and long-term surveillance extends beyond surgery.